Patent Assignment
Reel/Frame 022091/0205
Assignment of Assignor's Interest
Recorded: 2009-01-12
Pages: 5
Assignee
GTC BIOTHERAPEUTICS, INC.
175 CROSSING BOULEVARD, SUITE 410, FRAMINGHAM, MASSACHUSETTS, 01702
Covered Property
(1)
Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
Application:
11/586,431 →
Publication:
US 2008/0118501
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U.
Reel/Frame 022019/0205 →
Security Interest in Patent Licenses to Gtc Biotherapeutics, Inc.
Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U
Reel/Frame 022019/0273 →
Assignment of Assignor's Interest
Jan 12, 2009
From: EDMUNDS, TIMOTHY; MCPHERSON, JOHN
To: GENZYME CORPORATION
Reel/Frame 022091/0175 →
Security Interest in Patent Licenses to Gtc Biotherapeutics, Inc.
Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0936 →
Security Agreement
Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0854 →
Change of Name
Jul 18, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 030831/0081 →
Release of Security Interest
Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Release of Security Interest
Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →
Assignment of Assignor's Interest
May 8, 2014
From: REVO BIOLOGICS, INC.
To: LFB USA, INC.
Reel/Frame 032846/0110 →